Total Valuation
Aspen Pharmacare Holdings has a market cap or net worth of €3.59B. The enterprise value is €4.78K.
Market Cap€3.59B
Enterprise Value€4.78K
Share Statistics
Aspen Pharmacare Holdings has 432,921,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding432,921,450
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aspen Pharmacare Holdings’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 5.60%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)5.60%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee3.66M
Profits Per Employee-93.21K
Employee Count9,557
Asset Turnover0.33
Inventory Turnover1.51
Valuation Ratios
The current PE Ratio of Aspen Pharmacare Holdings is 26.1. Aspen Pharmacare Holdings’s PEG ratio is ―.
PE Ratio26.1
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.80
Price to FCF0.00
Price to Operating Cash Flow10.04
PEG Ratio―
Income Statement
In the last 12 months, Aspen Pharmacare Holdings had revenue of 34.98B and earned 2.66B in profits. Earnings per share was 5.96.
Revenue34.98B
Gross Profit14.10B
Operating Income5.42B
Pretax Income-419.32M
Net Income2.66B
EBITDA7.34B
Earnings Per Share (EPS)5.96
Cash Flow
In the last 12 months, operating cash flow was 6.94B and capital expenditures -2.16B, giving a free cash flow of 4.78B billion.
Operating Cash Flow6.94B
Free Cash Flow4.78B
Free Cash Flow per Share11.03
Dividends & Yields
Aspen Pharmacare Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change75.23%
50-Day Moving Average7.87
200-Day Moving Average6.92
Relative Strength Index (RSI)56.71
Average Volume (3m)122.00
Important Dates
Aspen Pharmacare Holdings upcoming earnings date is Mar 11, 2027, TBA (Confirmed).
Last Earnings DateSep 2, 2026
Next Earnings DateMar 11, 2027
Ex-Dividend Date―
Financial Position
Aspen Pharmacare Holdings as a current ratio of 2.54, with Debt / Equity ratio of 19.37%
Current Ratio2.54
Quick Ratio1.68
Debt to Market Cap0.24
Net Debt to EBITDA-0.06
Interest Coverage Ratio3.51
Taxes
In the past 12 months, Aspen Pharmacare Holdings has paid 471.48M in taxes.
Income Tax471.48M
Effective Tax Rate-1.12
Enterprise Valuation
Aspen Pharmacare Holdings EV to EBITDA ratio is 8.56, with an EV/FCF ratio of 13.25.
EV to Sales1.80
EV to EBITDA8.56
EV to Free Cash Flow13.25
EV to Operating Cash Flow9.12
Balance Sheet
Aspen Pharmacare Holdings has €15.76B in cash and marketable securities with €36.46B in debt, giving a net cash position of €422.70M billion.
Cash & Marketable Securities€15.76B
Total Debt€36.46B
Net Cash€422.70M
Net Cash Per Share€0.98
Tangible Book Value Per Share€82.04
Margins
Gross margin is 40.31%, with operating margin of 15.48%, and net profit margin of 7.59%.
Gross Margin40.31%
Operating Margin15.48%
Pretax Margin-1.20%
Net Profit Margin7.59%
EBITDA Margin20.98%
EBIT Margin15.48%
Analyst Forecast
The average price target for Aspen Pharmacare Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-19.32%
EPS Growth Forecast―